If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2002-2007 Postdoctoral training in Hematology and Oncology, Mount Sinai School of Medicine, New York, USA
  • 1997.09-2002.05 PhD., in Biology, City University of New York, USA
  • 1994.09-1997.07 M.S., in Biology, City University of New York , USA
  • 1984.09-1988.06 B.S.,  Department of Plant Pathology, National Chung Hsing University

Experience

  • 2013.02- Associate Professor, Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan
  • 2009.08-2013.07 Assistant Professor, Graduate Institute of Medical Sciences, Taipei Medical University, Taiwan
  • 2009.02-2009.07 Assistant Professor, Institute of Microbiology & Immunology, Chung Shan medical University, Taichung, Taiwan
  • 2007-2008 Research Associate, Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
  • 1994-2008 Postdoctoral Fellow , Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
  • 1994-2001 Adjunct Lecturer, Biology, Queens College, City University of New York

Awards

  • 2007 Travel Award, ASH 50th Annual Meeting, San Diego, CA

Research Interests

  • Leukocyte trafficking, Cancer biology, Wound healing, Traumatic brain injury

Fingerprint Dive into the research topics where Jung-Shan Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Neoplasms Medicine & Life Sciences
Neutrophils Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Tumors Chemical Compounds
Micelles Medicine & Life Sciences
E-Selectin Medicine & Life Sciences
Stomach Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2020

Research Output 2000 2018

  • 822 Citations
  • 12 h-Index
  • 23 Article
1 Citation (Scopus)

EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer

Cheng, C. C., Chou, K. F., Wu, C. W., Su, N. W., Peng, C. L., Su, Y. W., Chang, J., Ho, A. S., Lin, H. C., Chen, C. G. S., Yang, B. L., Chang, Y. C., Chiang, Y. W., Lim, K. H. & Chang, Y. F., Feb 1 2018, In : Lung Cancer. 116, p. 80-89 10 p.

Research output: Contribution to journalArticle

Nuclear Factor 90 Proteins
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Neoplasms
Therapeutics
3 Citations (Scopus)

Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers

Cheng, C. C., Lin, H. C., Tsai, K. J., Chiang, Y. W., Lim, K. H., Chen, C. G. S., Su, Y. W., Peng, C. L., Ho, A. S., Huang, L., Chang, Y. C., Lin, H. C., Chang, J. & Chang, Y. F., Nov 1 2018, In : Molecular Carcinogenesis. 57, 11, p. 1588-1598 11 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Epidermal Growth Factor
Neoplasms
RNA Sequence Analysis
Head and Neck Neoplasms
3 Citations (Scopus)

STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening

Cheng, C. C., Liao, P. N., Ho, A. S., Lim, K. H., Chang, J., Su, Y. W., Chen, C. G. S., Chiang, Y. W., Yang, B. L., Lin, H. C., Chang, Y. C., Chang, C. C. & Chang, Y. F., Aug 2 2018, In : Journal of Biomedical Science. 25, 1, 60.

Research output: Contribution to journalArticle

STAT3 Transcription Factor
Epidermal Growth Factor Receptor
Neoplastic Stem Cells
Colorectal Neoplasms
Screening
6 Citations (Scopus)

Significance of histone methyltransferase SETDB1 expression in colon adenocarcinoma

Ho, Y. J., Lin, Y. M., Huang, Y. C., Chang, J., Yeh, K. T., Lin, L. I., Gong, Z., Tzeng, T. Y. & Lu, J. W., Nov 1 2017, In : APMIS. 125, 11, p. 985-995 11 p.

Research output: Contribution to journalArticle

Colon
Adenocarcinoma
Proteins
Survival
histone methyltransferase
6 Citations (Scopus)

YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells

Cheng, C. C., Chang, J., Huang, S. C. C., Lin, H. C., Ho, A. S., Lim, K. H., Chang, C. C., Huang, L., Chang, Y. C., Chang, Y. F. & Wu, C. W., Aug 1 2017, In : PLoS One. 12, 8, e0182149.

Research output: Contribution to journalArticle

protein phosphorylation
lung neoplasms
Epidermal Growth Factor Receptor
Lung Neoplasms
Cells